Metformin-clinical pharmacology in PCOs.

Ramona Dumitrescu, Claudia Mehedințu, I Briceag, Victor Lorín Purcărea, D. Hudiță

PubMed · 2016 · 54 citations · 28 references

Full text

Open access

Concepts

Abstract

Oligo-anovulation, hyperandrogenism and insulin resistance characterizes polycystic ovary syndrome (PCOs). Metformin is the oldest insulin sensitizer used in the management of type 2 diabetes mellitus. In PCOs, metformin decreases the serum lipids, androgen and insulin; induces ovulation and regular menstrual cycle; increases the pregnancy rate.

References

28